SOSatomi Odani

Satomi Odani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Satomi Odani has a total of 105 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Trends and Transition Dynamics of Heated Tobacco Product Use in Japan, 2015–2025: A Repeated Cross-Sectional and Longitudinal Study

    by Satomi Odani, Takahiro Tabuchi

    Background: Heated tobacco products (HTPs) diffused rapidly in Japan, but transition dynamics remain unclear. We examined trends in HTP use and routes underlying growth.Methods: Using data from the Japan Society and New Tobacco Internet Survey, 2015–2025, we estimated weighted prevalence of HTP use (N=161,583). Sex- and age-standardised prevalence was used to estimate segmented trends with a 2018 knot. Among respondents observed in consecutive years (93,540 pairs), we fit a multinomial transition model across five states (Never, Non-current, Cigarette-only, HTP-only, and Dual use) and decomposed changes in standardised HTP prevalence into four categories: uptake from Never/Non-current use, switching from Cigarette-only to HTP, switching back to Cigarette-only, and exit to Non-current use.Findings: Weighted HTP prevalence increased from 0·1% to 14·9% during 2015–2025. Standardised prevalence rose sharply through 2018 (3·33 percentage points/year) and more gradually thereafter (0·92 points/year). Transition probabilities showed post-2018 persistence of HTP-only/Dual use (67·9% and 57·0%, respectively). In the longitudinal decomposition, mean annual entry into HTP use increased from 2·16 percentage points before 2018 to 3·48 after 2018, while mean annual exit increased in magnitude from −0·39 to −2·30. After 2018, uptake from Never/Non-current groups increased markedly, while switching from Cigarette-only to HTP remained substantial.Interpretation: HTP use in Japan shifted around 2018 from rapid expansion to slower but sustained growth. Growth reflected not only cigarette-to-HTP switching but also increasing uptake beyond current smokers, indicating that HTP population impact cannot be understood through a substitution-only framework.

  • Open Access

    Healthcare Providers’ Advice for Tobacco Cessation and Its Association with Quit Attempts: A Cross-Sectional Study in Japan, 2024

    by Satomi Odani, Takahiro Tabuchi

    Background:Despite guideline recommendations to deliver cessation advice, implementation in Japan remains inconsistent. We examined tobacco use prevalence, receipt of healthcare providers' advice, and its association with quit attempts.Methods:We analyzed the 2024 wave of a nationwide web-based survey (N=27,374; ages 16–74). Non-probability quota sampling and post-stratification weighting were used to approximate national population distributions. Current (past-30-day) tobacco use was assessed for heated tobacco products (HTPs), cigarettes, non-cigarette combustible tobacco, and dual use (HTPs plus combustible). Exposure was receipt of healthcare providers’ advice, and outcome was quit attempt in the past year. Associations were analyzed using multivariable Poisson regression to obtain adjusted prevalence ratios (APRs) and 95% confidence intervals (CIs).Results:Overall, 24.2% reported current any tobacco product use: 12.9% HTPs, 17.8% cigarettes, 3.7% non-cigarette combustible, and 7.3% dual use. Among any tobacco users (N=6,361), 13.2% received advice and 26.7% attempted to quit. Among any tobacco users currently receiving medical care (N=2,779), 20.9% received advice, primarily from doctors (10.3%) and nurses (8.0%), and 29.9% attempted to quit. Compared with no advice, quit attempts were more likely when advice came from one professional (APR, 1.28; 95% CI, 1.05–1.58) or multiple professionals (APR, 1.61; 95% CI, 1.17–2.23). Exclusive HTP users were less likely than exclusive combustible tobacco smokers to attempt quitting (APR, 0.57; 95% CI, 0.41–0.81).Conclusion:Receipt of providers’ advice remains low in Japan yet is strongly associated with quit attempts, especially with multi-professional involvement. Policy, training, and system-level supports are needed to strengthen provider engagement.


  • Open Access

    Association of COVID-19 Vaccine Intake with Diagnosis, Hospitalization, and Oxygenation/Ventilation: A Longitudinal Analysis, 2021–2022, Japan

    by Satomi Odani, Hitoshi Honda, Takahiro Tabuchi

    Background/Objectives: Japan’s COVID-19 vaccination campaign achieved high coverage by 2022, yet limited national-level data has hindered evaluations of vaccine effectiveness. This study analyzed the impact of vaccines on infection outcomes while considering socioeconomic and behavioral factors in the Japanese population. Methods: A total of 19,482 individuals aged 16–81 years, who participated in both the 2021 (baseline) and 2022 (follow-up) waves of an Internet-based survey, were analyzed. Vaccine intake during the follow-up period (0/1/2+ doses) served as the exposure, while outcomes included COVID-19 diagnosis, hospitalization, and receipt of oxygenation/ventilation. Adjusted prevalence ratios (APRs) were calculated using Poisson regression models, controlling for baseline characteristics such as vaccination status, infection history, underlying medical conditions, socioeconomic factors, and preventive behaviors. Results: Overall, 81.6% of respondents received at least 1 dose of COVID-19 vaccine during the follow-up period. Among those without COVID-19 history at baseline (N = 19,182), 10.9% were diagnosed with COVID-19 in the past year, and 6.6% in the past 2 months. Respondents who received 1 or 2+ doses had lower diagnosis rates (APR = 0.76 and 0.43, respectively). For the past 2 months, only those with 2+ doses showed a significant reduction (APR = 0.51). Among 1999 diagnosed cases, those with 1 or 2+ doses showed lower hospitalization and oxygenation/ventilation likelihoods, though these differences were not statistically significant. Conclusions: The results supported the protective effect of COVID-19 vaccines against infection. Continued research is essential to further clarify the complex influence of vaccination, individual characteristics, and preventive behaviors on COVID-19 morbidity at the population level.


  • Open Access

    Impacts of revised smoke-free regulations under the 2020 Japan Health Promotion Act on cigarette smoking and heated tobacco product use in indoor public places and homes: findings from 2018 to 2021 International Tobacco Control (ITC) Japan Surveys

    by Kayo Togawa, Geoffrey T Fong, Anne C K Quah, Gang Meng, Steve S Xu, Janine Quimet, Yumiko Mochizuki, Itsuro Yoshimi, Satomi Odani, Takahiro Tabuchi, et al.

    Background In April 2020, Japan’s revised Health Promotion Act (HPA) banned cigarette smoking and heated tobacco products (HTP) use in indoor public places but exempted small establishments and permitted smoking-designated/HTP-designated rooms. This pre–post study evaluated the effectiveness of the HPA. Methods Data were from waves 1 to 4 (2018–2021) of the International Tobacco Control Japan Surveys among a national cohort of adults who smoke cigarettes, use HTPs and do not use any tobacco products. The sample sizes in the respective surveys were 4615, 4222, 4387 and 4254. Multivariable logistic regression models employing generalised estimating equations estimated the prevalence of observed and self-reported indoor smoking/HTP use in key public venues (restaurants/cafés, bars/pubs and workplaces), smoke-free places, and homes, and smoke-free/HTP aerosol-free home policies (model 1). The models were additionally adjusted for waves 1–4 to estimate the impacts of the HPA (model 2). Results The implementation of the HPA significantly reduced observed indoor smoking in bars/pubs (model 1: 82.2% (pre) to 55.5% (post), model 2: p=0.04) but not in restaurants/cafés (model 1: 53.0%–24.9%, model 2: p=0.15) or workplaces (model 1: 35.3%–30.1%, model 2: p=0.62). Observed indoor HTP use was also common postimplementation (restaurants/cafés: 19.6%, bars/pubs: 53.9%, workplaces: 36.4%). The implementation of the HPA was associated with a significant increase in observed HTP use in smoke-free places (model 1: 26.3%–33.3%, model 2: p=0.001) and a suggestive increase in homes without HTP aerosol-free policies among adults who smoke (model 1: 64.0%–77.0%, model 2: p=0.09). Conclusions The implementation of the HPA was limited in its effectiveness. Comprehensive regulations with no exemptions are needed in Japan.


  • Open Access

    Association between heated tobacco product use and airway obstruction: a single-centre observational study, Japan

    by Satomi Odani, Shihoko Koyama, Isao Miyashiro, Hironobu Tanigami, Yoshifumi Ohashi, Takahiro Tabuchi

    Background While heated tobacco products (HTPs) may affect pulmonary function, the evidence supporting the utility of screening for HTP use in clinical settings is insufficient. We examined the association between HTP use and airway obstruction after switching from cigarettes. Method The study subjects were patients aged ≥20 years undergoing surgery from December 2021 to September 2022 who completed spirometry and reported tobacco (cigarette and HTP) use status during the preoperative assessment. Airway obstruction was defined as forced expiratory volume in 1 s to forced vital capacity ratio below the lower limit of normal. Current tobacco use was defined as past-30-day use. Multivariable Poisson regression analysis was performed to examine the associations between HTP use and airway obstruction by adjusting for demographic characteristics, lifetime cigarette smoking (pack-year) and duration of smoking cessation. Results Overall (N=2850, 55.4% women, mean age 62.4), 4.6% and 10.7% reported current HTP use and cigarette smoking, respectively. 16.8% had airway obstruction. Airway obstruction was more common among current HTP-only users (adjusted prevalence ratio (APR)=2.32), current cigarette-only smokers (APR=2.57) and current dual users (APR=2.82) than never-tobacco users. Among current tobacco users (N=398), the prevalence of airway obstruction was not significantly different between HTP-only users and cigarette-only smokers. Among former cigarette smokers (>30-day cigarette quitters) (N=1077), current HTP users had 1.42 times the increased prevalence of airway obstruction than never-HTP users after adjusting for cigarette pack-year; a stronger association was observed when the analysis was restricted to ≥5-year cigarette quitters (N=772) (APR=1.96, vs never HTP users). Conclusion Current HTP use was associated with airway obstruction among patients with cancer who had completely switched from cigarettes even after quitting smoking for a long period. Patients should be routinely screened for HTP use and advised to quit any tobacco.


  • Open Access

    Gender differences in use of cigarette and non-cigarette tobacco products among adolescents aged 13–15 years in 20 African countries

    by Israel T. Agaku, Rose Sulentic, Adriana Dragicevic, Gibril Njie, Candace K. Jones, Satomi Odani, Tina Tsafa, Joy Gwar, Constantine I. Vardavas, Olalekan Ayo-Yusuf

    Introduction: Examining gender differences in youth tobacco use is important as it aligns tobacco control within the context of broader human development goals seeking to eliminate gender inequalities. In this study, we examined gender differences in adolescent use of cigarettes, smokeless...


  • Heated tobacco products do not help smokers quit or prevent relapse: a longitudinal study in Japan

    by Satomi Odani, Kanami Tsuno, Israel T Agaku, Takahiro Tabuchi

    Background Heated tobacco products (HTPs) are often marketed as a safer alternative to help cigarette smokers quit. We investigated the link between HTP use and smoking cessation and relapse. Methods 7044 adults (≥20 years old) with at least two observations over three waves (2019–2021) of a longitudinal, nationwide, internet-based survey were classified into current (past 30-day), former and never cigarette smokers. ≥1 month and ≥6 months smoking cessation and smoking relapse at 1-year follow-up were assessed in relation to current HTP use at baseline. Generalised estimating equation models were weighted to account for population differences between HTP users and non-users. Adjusted prevalence ratios (APRs) were computed within population subgroups. Results At baseline, 17.2%, 9.1% and 6.1% of the respondents were current cigarette smokers, HTP users and dual users, respectively. Among current established smokers (having smoked regularly, n=1910), HTP use was significantly associated with a decreased likelihood of ≥1 month cessation within those who reported having used evidence-based cessation measures (APR=0.61), smoking 20+ cigarettes per day (APR=0.62), high school education or less (APR=0.73) and fair/poor health (APR=0.59). Negative associations were also seen for ≥6 months cessation among those aged 20–29 years (APR=0.56) and full-time workers (APR=0.56). Among former smokers (n=2906), HTP use was associated with smoking relapse within those who last smoked >1 year ago (APR=1.54), among women (APR=1.61), those aged 20–29 years (APR=2.09), those reporting high school education or less (APR=2.36), those who were unemployed/retired (AOR=3.31) and never/non-current alcohol users (APR=2.10). Conclusion HTP use did not help smokers quit or prevent former smokers from relapsing. HTPs should not be recommended as a cessation aid.


  • Open Access

    Dentist versus physician cessation counselling: A secondary analysis of the US Tobacco Use Supplement to the Current Population Survey

    by Israel Agaku, Satomi Odani, Lungile Nkosi, Joy Gwar, Tina Tsafa

    Introduction: We investigated associations between counseling by a dentist or physician and quit intentions/attempts using longitudinal data. Methods: Analyses were performed with longitudinal data from the 2010–2011 Tobacco Use Supplement to the Current Population Survey (TUS-CPS)....

  • Open Access

    Attitudes toward COVID-19 vaccination during the state of emergency in Osaka, Japan

    by Satomi Odani, Shihoko Koyama, Yuichi Katsumi, Isao Miyashiro

    Background: COVID-19 vaccination for general population started on April 12, 2021, in Osaka, Japan. We investigated public attitudes toward vaccination and associated factors of vaccine hesitancy during the third state of emergency. Methods: An internet-based, self-reported, cross-sectional survey was conducted in June 2021, using the smartphone health app for residents of Osaka aged ≥18 years. Respondents were asked about their attitudes toward COVID-19 vaccine. Responses “Don’t want to receive vaccines” or “Don’t know” were defined as vaccine hesitancy (vs. “Received [1st dose]”, “Received [2nd dose]”, or “Want to receive vaccines”). Multivariable Poisson regression analysis was conducted to examine the associations between hesitancy and population characteristics. Results: 23,214 individuals (8,482 men & 14,732 women) were included in the analysis. Proportions that answered “Received (1st dose)”, “Received (2nd dose)”, “Want to receive vaccines”, “Don’t want to receive vaccines”, “Don’t know”, and “Don’t want to answer” were 14.6%, 3.8%, 70.6%, 4.3%, 6.1%, and 0.5% among men; and 11.3%, 6.0%, 64.9%, 6.2%, 11.0%, and 0.6% among women. Factors associated with vaccine hesitancy included being a woman (aPR = 1.33; 95%CI = 1.23–1.44), age 18–39 (aPR = 7.00; 95%CI = 6.01–8.17) and 40–64 years (aPR = 4.25; 95%CI = 3.71–4.88 vs. 65+ years), living alone (aPR = 1.19; 95%CI = 1.08–1.30 vs. living with 3+ members), non-full-time employment and unemployment (aPRs ranged 1.12 to 1.49 vs. full-time employment), cardiovascular diseases/hypertension (aPR = 0.72; 95%CI = 0.65–0.81), and pregnancy (women of reproductive age only) (aPR = 1.35; 95%CI = 1.03–1.76). Conclusions: Most respondents expressed favorable attitudes toward COVID-19 vaccination while hesitancy was disproportionately high in certain populations. Efforts are needed to ensure accessible vaccine information resources and healthcare services.